Singapore Economic Development Board

Singapore Economic Development Board

Singapore Economic Development Board

Overview
Headquarters

250 North Bridge Road,27-40 Raffles City Tower,Singapore 179101

Type of Company

Private

Industries

Government
Investment Services & Portfolio Management

Company Description

The Economic Development Board is a statutory board of the Government of Singapore that plans and executes strategies to sustain Singapore as a leading global hub for business and investment.

Executives & Employees

Center Director

Managing Director

Director-North America

International Director, Americas

Director-Western United States & Canada

Assistant Managing Director

Assistant Managing Director

Assistant Managing Director

Assistant Managing Director

Special Advisor

Board of Directors

Former Vice Chairman at EDB Investments Pte Ltd.

Chief Executive Officer & Executive Director at Keppel Corp. Ltd.

President, Chief Executive Officer & Executive Director at SATS Ltd.

Chief Executive Officer, Asia-Pacific at Deloitte & Touche LLP (Singapore)

Chief Executive Officer & Non-Independent Executive Director at Singapore Exchange Limited

President-Asia Pacific, Middle East & Africa at Procter & Gamble Co.

Former Chief Executive Officer at JTC Corporation

President, Alstom Singapore at Alstom SA

Dean at INSEAD

Managing Director at Singapore Economic Development Board

Paths to Singapore Economic Development Board
Potential Connections via
Relationship Science
You
Singapore Economic Development Board
Recent Transactions
Details Hidden

EDB Investments Pte Ltd., EDBI Pte. Ltd. purchase Greenwave Systems

Details Hidden

MBK Partners, Ltd., Luye Pharma Group Ltd., Luye-Biotech (Singapore) Pte Ltd. purchase A-Bio Pharma Pte Ltd. from Singapore Economic Development Board, Bio One Capital Pte Ltd.

Details Hidden

Micron Technology, Inc. purchases TECH Semiconductor Singapore Pte Ltd. from Singapore Economic Development Board

Investments
Details Hidden

ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Singapore Economic Development Board. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Singapore Economic Development Board's profile does not indicate a business or promotional relationship of any kind between RelSci and Singapore Economic Development Board.